Pharmacological activation of peroxisome proliferator‐activated receptor γ (PPAR‐γ) protects against hypoxia‐associated fetal growth restriction. Issue 8 (30th April 2019)

• Record Type: Journal Article
• Authors: Lane, Sydney L.; Blair Dodson, R.; Doyle, Alexandrea S.; Park, Haemin; Rathi, Hinal; Matarrazo, Christopher J.; Moore, Lorna G.; Lorca, Ramón A.; Wolfson, Gabriel H.; Julian, Colleen G.
• Is Part Of: FASEB journal. Volume 33:Issue 8(2019)
• Page Start: 8999
• Page End: 9007
• Publication Date: 2019-04-30
• Subjects: altitude -- IUGR -- placenta -- vascularity -- pioglitazone; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201900214R
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: The hypoxia of high‐altitude (HA) residence increases the risk of intrauterine growth restriction (IUGR) and preeclampsia 3‐fold, augmenting perinatal morbidity and mortality and the risk for childhood and adult disease. Currently, no effective therapies exist to prevent these vascular disorders of pregnancy. The peroxisome proliferator‐activated receptor γ (PPAR‐γ) is an important regulator of uteroplacental vascular development and function and has been implicated in the pathogenesis of IUGR and preeclampsia. Here, we used a model of HA pregnancy in mice to determine whether hypoxia‐induced fetal growth restriction reduces placental PPAR‐γ protein expression and placental vascularization and, if so, to evaluate the effectiveness of the selective PPAR‐γ agonist pioglitazone (PIO) for preventing hypoxia‐induced IUGR. Hypoxia resulted in asymmetric IUGR, placental insufficiency, and reduced placental PPAR‐γ expression; PIO prevented approximately half of the fetal growth restriction and attenuated placental insufficiency. PIO did not affect fetal growth under normoxia. Although PIO was beneficial for fetal growth, PIO treatment reduced placental vascular density of the labrynthine zone in normoxic and hypoxic (Hx) conditions, and mean vascular area was reduced in the Hx group. Our results suggest that pharmacological PPAR‐γ activation is a potential strategy for preventing IUGR in pregnancies complicated by hypoxia, although further studies are needed to identify its likely metabolic or vascular mechanisms.—Lane, S. L., Dodson, R. B., Doyle, A. S., Park, H., Rathi, H., Matarrazo, C. J., Moore, L. G., Lorca, R. A., Wolf son, G. H. Julian, C. G. Pharmacological activation of peroxisome proliferator‐activated receptor γ (PPAR‐γ) protects against hypoxia‐associated fetal growth restriction. FASEB J. 33, 8999–9007 (2019). www.fasebj.org